Talazoparib |
Inhibitor of PARP1, PARP2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PARP1 |
|
|
| PARP2 |
|
|
Inhibitor
10-100 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - PARP3 62.8 nM, PARP4 254 nM, TNKS1 322 nM, TNKS2 108 nM
Potency Assay Off-Target:
No activity was detected against PARG to 1 uM. In in vitro ADP ribosylation assays, talazoparib was ...
Selectivity Assessment Description:
No activity was detected against PARG to 1 uM. In in vitro ADP ribosylation assays, talazoparib was ...
Potency Cellular
In Vitro
PARP1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b00990
PARP2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acs.jmedchem.6b00990
In Vivo Validations
Mouse
Dose: 1 mg/kg
Route of delivery:
Oral
Organ of interest (O):
MX-1 tumor xenograft
Target engagement assay:
In MX-1 xenografts, talazoparib inhibited PAR.
DOI Reference: 10.1158/1078-0432.CCR-13-1391
Chemical Information
| Molecular Formula | C19H14F2N6O |
| SMILEs | Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1 |
| InChI | InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1 |
| Molecular weight | 380.12 Da |
| AlogP | 2.6285000000000007 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 42 |
References
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.